Moreover, Kim et al. demonstrated that epidermal growth factor (EGF) promoted HCC progression by inducing HDAC2 transcriptional activation in HCC cells via the CK2α/Akt signaling pathway (Kim et al., 2014). Here, HDAC2 is linked to hepatocellular carcinoma.